Ministry of Health Removes Evalar’s Levocarnitine Substance from GRLS

The Ministry of Health has excluded the registration certificate for the pharmaceutical substance levocarnitine (trade name: Levocarnitine) produced by Russian company Evalar from the GRLS. This drug is used globally for serious kidney diseases requiring dialysis. The decision was made based on a request from the registration holder, Evalar JSC, and the document was signed on March 20. Generic alternatives remain registered in the GRLS.